A comment on 'Glucagon-like peptide-1 receptor agonists and risk of thyroid cancer: A systematic review and meta-analysis of randomized controlled trials'. Goldenberg RM. Diabetes Obes Metab 2024;26:2997-2999.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Goldenberg RM. A comment on 'Glucagon-like peptide-1 receptor agonists and risk of thyroid cancer: A systematic review and meta-analysis of randomized controlled trials'. Diabetes Obes Metab 2024;26:2997-2999.
PMID: 38576082